胰腺癌生物学
Biology of pancreatic cancer.
作者信息
Poston G J, Gillespie J, Guillou P J
机构信息
Academic Surgical Unit, St Mary's Hospital Medical School, London.
出版信息
Gut. 1991 Jul;32(7):800-12. doi: 10.1136/gut.32.7.800.
Abstract
Pancreatic cancer is the fifth leading cause of death from malignant disease in Western society. Apart from the fortunate few patients who present with a resectable small pancreatic adenocarcinoma, conventional treatment offers no hope of cure and has little palliative value. Over the past two decades major steps have been made in our understanding of the biology of pancreatic growth and neoplasia. This review sets out to explore these advances, firstly in the regulation of normal pancreatic growth, and secondly the mechanism which may be involved in malignant change of the exocrine pancreas. From an understanding of this new biology, new treatment strategies may be possible for patients with pancreatic cancer.
摘要
在西方社会，胰腺癌是恶性疾病导致死亡的第五大主要原因。除了少数幸运的可切除小胰腺癌患者外，传统治疗无法治愈，且几乎没有姑息治疗价值。在过去二十年里，我们对胰腺生长和肿瘤形成生物学的理解取得了重大进展。本综述旨在探讨这些进展，首先是正常胰腺生长的调节，其次是外分泌胰腺恶性变化可能涉及的机制。通过了解这种新生物学，有可能为胰腺癌患者制定新的治疗策略。
相似文献
1
Biology of pancreatic cancer.
Gut. 1991 Jul;32(7):800-12. doi: 10.1136/gut.32.7.800.
2
Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.
Int J Pancreatol. 1993 Jun;13(3):159-68. doi: 10.1007/BF02924436.
3
Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
Adv Exp Med Biol. 2013;779:91-143. doi: 10.1007/978-1-4614-6176-0_5.
4
Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis.
Dig Dis. 2001;19(1):32-6. doi: 10.1159/000050651.
5
Pancreatic cancer: a review of emerging therapies.
Drugs. 2000 May;59(5):1071-89. doi: 10.2165/00003495-200059050-00004.
6
Growth factors in development and diseases of the exocrine pancreas.
Pancreatology. 2001;1(1):15-23. doi: 10.1159/000055787.
7
Hormones and pancreatic cancer.
Int J Pancreatol. 1991 Summer;9:81-6. doi: 10.1007/BF02925582.
8
Experimental animal models of pancreatic carcinogenesis and metastasis.
Int J Gastrointest Cancer. 2003;33(1):43-60. doi: 10.1385/IJGC:33:1:43.
9
Targeting Notch signaling in pancreatic cancer patients--rationale for new therapy.
Adv Med Sci. 2009;54(2):136-42. doi: 10.2478/v10039-009-0026-3.
10
[Steroid hormones and pancreas: a new paradigm].
Rev Invest Clin. 2007 Mar-Apr;59(2):124-9.
引用本文的文献
1
Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer.
Cancer Cell Int. 2019 Feb 28;19:47. doi: 10.1186/s12935-019-0761-x. eCollection 2019.
2
Association of peripheral leukocyte telomere length and its variation with pancreatic cancer and colorectal cancer risk in Chinese population.
Oncotarget. 2016 Jun 21;7(25):38579-85. doi: 10.18632/oncotarget.9536.
3
How Grim is Pancreatic Cancer?
Oncol Rev. 2016 Jul 6;10(1):294. doi: 10.4081/oncol.2016.294. eCollection 2016 Apr 15.
4
E- and N-cadherin differ with respect to their associated p120ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells.
Oncogene. 2004 Jul 15;23(32):5532-42. doi: 10.1038/sj.onc.1207718.
5
Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma.
Dig Dis Sci. 2003 Oct;48(10):1972-8. doi: 10.1023/a:1026122421369.
6
p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth.
Mol Cancer. 2003 Nov 5;2:37. doi: 10.1186/1476-4598-2-37.
7
Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
Clin Exp Metastasis. 2002;19(5):417-26. doi: 10.1023/a:1016395316362.
8
Transforming growth factor alpha (TGF-alpha) increases cell number in a human pancreatic cancer cell line but not in normal mouse pancreas.
Int J Pancreatol. 2000 Dec;28(3):199-205. doi: 10.1385/IJGC:28:3:199.
9
NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
Br J Cancer. 2001 Mar 23;84(6):864-73. doi: 10.1054/bjoc.2000.1682.
10
Pancreatic cancer: a review of emerging therapies.
Drugs. 2000 May;59(5):1071-89. doi: 10.2165/00003495-200059050-00004.
本文引用的文献
1
DNA SYNTHESIS, MITOSIS, AND DIFFERENTIATION IN PANCREATIC ACINAR CELLS IN VITRO.
J Cell Biol. 1964 Mar;20(3):415-33. doi: 10.1083/jcb.20.3.415.
2
On the origin of cancer cells.
Science. 1956 Feb 24;123(3191):309-14. doi: 10.1126/science.123.3191.309.
3
Early alterations in rat colonic mucosal cyclic nucleotide metabolism and protein kinase activity induced by 1,2-dimethylhydrazine.
Cancer Res. 1980 Dec;40(12):4589-98.
4
Estrogen receptor proteins in diverse human tumors.
Arch Surg. 1980 Mar;115(3):244-8. doi: 10.1001/archsurg.1980.01380030004002.
5
The influence of starvation on intestinal cholecystokinin-like activity and pancreatic growth.
J Physiol. 1981 Dec;321:469-82. doi: 10.1113/jphysiol.1981.sp013997.
6
The effects of long-term feeding of soya flour on the rat pancreas.
Scand J Gastroenterol. 1980;15(4):497-502. doi: 10.3109/00365528009181507.
7
Ornithine decarboxylase enzyme activity in human and hamster pancreatic tumor cell lines.
Cancer Lett. 1982 Oct;17(1):87-93. doi: 10.1016/0304-3835(82)90113-6.
8
The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.
Br J Surg. 1982 Oct;69(10):595-7. doi: 10.1002/bjs.1800691013.
9
Stimulation of pancreatic secretion and growth in the rat after feeding cholestyramine.
Gastroenterology. 1982 Oct;83(4):851-9.
10
The distribution and metabolism of 14C-labelled tamoxifen in spayed female mice.
Acta Pharmacol Toxicol (Copenh). 1982 Mar;50(3):161-8. doi: 10.1111/j.1600-0773.1982.tb00958.x.
Zotero 插件